Business Context and Reporting Period
Company: Ingevity Corp (NGVT)
Filing Type: Form 10-Q (Unaudited)
Reporting Period: Quarter and six months ended June 30, 2025
Business Overview: Ingevity develops, manufactures, and markets solutions for adhesives, agrochemicals, asphalt paving, bioplastics, coatings, and automotive components. Operations are organized into three segments: Performance Materials, Performance Chemicals, and Advanced Polymer Technologies.
Key Financial Metrics
| Metric (in millions) | Q2 2025 | Q2 2024 | YTD 2025 | YTD 2024 |
|---|---|---|---|---|
| Net Sales | $365.1 | $390.6 | $649.1 | $730.7 |
| Gross Profit | $137.9 | $123.2 | $251.3 | $222.9 |
| Gross Margin | 37.8% | 31.5% | 38.7% | 30.5% |
| Net Income (Loss) | $(146.5) | $(283.7) | $(126.0) | $(339.7) |
| Diluted EPS | $(4.02) | $(7.81) | $(3.46) | $(9.36) |
| Adjusted EBITDA (Non-GAAP) | $110.0 | $101.3 | $201.3 | $175.7 |
| Operating Cash Flow (YTD) | $104.4 | $17.6 | $104.4 | $17.6 |
| Cash & Equivalents | $76.9 | $68.0 | $76.9 | $68.0 |
| Total Debt (incl. leases) | $1,334.0 | $1,405.2 | $1,334.0 | $1,405.2 |
Material Changes vs. Prior Period
- Revenue Decline: Net sales decreased 6.5% in Q2 2025 and 11.2% YTD compared to 2024. The decline was driven by volume decreases of 10% (Q2) and 13% (YTD), partially offset by favorable pricing and mix.
- Performance Chemicals: Sales dropped due to strategic repositioning (exiting lower-margin industrial specialties) and wet weather delaying road construction projects.
- Advanced Polymer Technologies: Sales declined due to weaker demand and tariff-related uncertainty.
- Goodwill Impairment: A non-cash goodwill impairment charge of $183.8 million was recorded in Q2 2025, attributed entirely to the Advanced Polymer Technologies (APT) segment. This was driven by escalated global trade tensions, tariff impacts, and unfavorable valuation inputs (increased risk-free rates).
- Restructuring Charges: Total restructuring and other charges were $21.9 million in Q2 2025 ($34.2 million YTD), primarily related to the ongoing Performance Chemicals repositioning (plant closures, workforce reductions).
- Profitability Improvement (Excluding Impairments): Despite the impairment charge, Adjusted EBITDA increased 8.6% in Q2 and 14.6% YTD. Gross margin expanded significantly due to lower raw material costs (specifically Crude Tall Oil), LIFO liquidation benefits, and realized cost savings from restructuring.
- Cash Flow: Operating cash flow improved dramatically to $104.4 million YTD 2025 from $17.6 million in 2024, driven by reduced CTO resale cash outflows and improved working capital management.
Guidance, Outlook, and Risks
- 2025 Full Year Guidance:
- Net Sales: Reaffirmed at $1.25 billion to $1.40 billion.
- Adjusted EBITDA: Revised upward to $390 million to $415 million, reflecting improved profitability in Performance Chemicals.
- Segment Outlook:
- Performance Materials: Sales expected to be similar to 2024; EBITDA margins expected to remain around 50%.
- Performance Chemicals: Road technologies expected to grow modestly; Industrial specialties projected at $160M-$200M. EBITDA margins expected in high-single to low-double digits.
- Advanced Polymer Technologies: Sales expected to decline mid-to-high single digits; EBITDA margins expected in mid-teens to low-20% range.
- Key Risks & Contingencies:
- Legal Proceedings: A $85.0 million trebled jury verdict (plus accrued interest totaling $93.4 million as of June 30, 2025) remains outstanding from an antitrust counterclaim by BASF. Ingevity is appealing the verdict.
- Trade Policy: Recent tariff announcements and retaliatory measures (particularly from China) pose risks to export costs and demand.
- Raw Materials: While exposure to Crude Tall Oil (CTO) has decreased due to repositioning, commodity price volatility remains a risk.
- Repositioning Execution: Risks associated with the closure of the DeRidder and Crossett facilities and the transition of operations.
Investor Verification Checklist
- Goodwill Impairment Assumptions: Verify the specific discount rates and revenue growth assumptions used in the APT impairment analysis, as these are highly judgmental.
- BASF Litigation Status: Monitor the timeline and potential outcome of the appeal regarding the $85 million antitrust verdict and associated interest accruals.
- Performance Chemicals Repositioning: Track the realization of the projected $110 million in remaining cash charges and the $103 million in cash savings already realized.
- Tariff Impact: Assess the actual impact of new global tariffs on the Advanced Polymer Technologies segment, which is currently facing demand weakness.
- Debt Covenants: Confirm continued compliance with the 4.0x net leverage ratio and 3.0x interest coverage ratio, though current metrics (2.9x leverage, 5.0x coverage) indicate a comfortable position.